Attention Hiring Group
RE: Opportunities in discovery and pre-clinical drug development Senior
Management.
Dear Hiring Manager(s),
My roles, experience, and accomplishments in the pharmaceutical and CRO business
are strong and diverse. I believe this makes me a well qualified candidate for
senior management in the Discovery and Pre Clinical Drug Development /
Pharmacology / DM/PK / Toxicology industry.
With 14 years in the pharmaceutical industry (AstraZeneca R&D) and CRO business
(MDS Pharma Services, Algos Preclinical Services and LAB Research Canada), my
experience in clinical and pre-clinical drug industry is strong and diversified.
As shown on my resume, I have extensive expertise in drug development from the
Target Identification to Candidate Drug nomination, leading to IND filing,
in-licensing. In my role as President I was responsible for due diligence, team
management, administration and finance (P I can lead drug discovery programs,
multidisciplinary teams of scientists, business development and finance to
deliver expected results within budget, and strive to exceed drug development
targets with respect of the companies' vision and core values. I also have an
excellent knowledge of new facility design and Global Accreditation (i.e. AAALAC
intl).
The enclosed resume will further highlight my qualifications. I look forward to
discussing further with you how my background and experience can benefit your
company.
Respectfully yours,
Daniel Ménard, Ph.D.
445 S. 210th St
Seattle WA 98198
620, Des Charentes,
Rosemere, Quebec, Canada
514 627 2347
American & Canadian Citizen
MENARD, Daniel (Ph.D.)
TEL: (514) 627-2347 (mobile)
Email: (private)
445 S. 210th St
Seattle WA 98198
GENERAL INFORMATION
CITIZENSHIP : American/Canadian
LANGUAGES : French, English
HIGHLIGHTS OF QUALIFICATIONS:
* 18 years global pharmaceutical industry experience in R&D
* Achievements in project management end to end Candidate Drug (CD) nomination
and Investigational New Drug (IND) filling
* Clinical and fundamental experience in CNS, PNS, CV, oncology, infectious
diseases, metabolic diseases and inflammatory disorders
* In vivo, in vitro pharmacology, toxicology and DM/PK (ADMET) experience
* Background in Administration, Operations and P&L
* Expertise in laboratory, equipment and new facility design and set up
* Contract Research Organization (CROs) evaluation, negotiation, recruitment,
in-licensing, due diligence and acquisition
* Business Development support for North America, Asia and Europe
* Trained in lean and six sigma
* Experience in IT/IS server and database administration
* Oversee MDS Pharma Service's most extensive range of pharmacology services
for profiling compound's specificity and selectivity, and for determining the
potential for adverse events, ADME, and PK/PD in chronic disease models
* Managed a global organization including sites in Bothell USA, Montreal Canada
and Taipei Taiwan
* Experienced in private pre-clinical CRO (ALGOS Pre-Clinical)
* Experienced in public non-clinical CRO (LAB research, toxicology)
EXPERIENCE
LAB Research Inc. 2009-2010
President
MAJOR AREAS OF RESPONSIBILITY
* Responsible for all scientific operations including laboratories, toxicology
operations, pathology, human resources, finance, quality assurance, building,
IT/IS and business development
* Accountable for full profit and loss for the Canadian site
* Responsible strategic planning, site management and development, site
revenues and profitability, human resources management and development
ALGOS Therapeutics Inc. 2007-2009
President & CEO 2008-2009
President, CSO & COO 2007-2008
Algos is privately held research company located in St. Paul, Minnesota with a
well-respected and growing pre-clinical pain research contract service
organization. Algos provides a comprehensive offering of high quality
pre-clinical pain research services, specializing in behavioral pain models.
Clients include many of the world's leading pharmaceutical research
organizations.
MAJOR AREAS OF RESPONSIBILITY:
* Managed the scientific staff, work closely with Algos' board and clients
* Led the development of the strategy for the company's growth
* Streamlined operational efficiencies, identified and developed new service
offerings, and positioned the company for continued, sustainable and profitable
growth
* Developed and guided key business strategies for attaining the company's
goals
* Coordinated research operations staff
* Prepared and managed annual operations budget
* Oversaw hiring, supervision and training of scientific staff
* Oversaw facility improvements
MDS Pharma Services 2001-2006
MDS Pharma Services (Early Stage Development) 2004-2006
Vice President, General Manager, Pharmacology & DM/PK
MAJOR ARAS OF RESPONSIBILITY:
* Screening, HTS custom assays, cellular assays, ion channels in Bothell
WA.(USA)
* Pharmacology profiling, Taipei Taiwan
* Due diligence, strategic alliances, in-licensing, acquisitions and
integration
* Global business development and marketing
* DMPK, ADME Montreal, Canada
* Managed a team of 260 employees
MDS Pharma Services (Early Stage Development) 2003-2004
Vice President Pharmacology Operations
MAJOR AREAS OF RESPONSIBILITY:
* Directed the research activities to attain overall Pharmacology objectives,
in line with the mission and the orientations of MDSPS
* Coordinated pharmacology operations for efficiency while meeting budgetary
controls.
* Kept abreast of scientific and technological developments in the field
enabling pharmacology to make use of all applicable innovations
* Conceptualized innovative approaches and methods
* Provided scientific, technical and consulting services in pharmacology to
scientific and managerial personnel at pharmaceutical company clients
* Provided CD results interpretation, made recommendations for new and
alternative uses applications, resulting in compound new therapeutic indication
* Enhanced effectiveness of product and service sales team by providing
technical support
* Maintained close relationships within the drug development industry to
increase the visibility of MDS Pharma Services
MDS Pharma Services (Drug discovery, Development, and Preclinical) 2002
Director of Pharmacology
MAJOR AREAS OF RESPONSIBILITY
* Managed for the scientific portfolio of pharmacology services
* Served as drug development consultant to multiple client companies
* Provided business development support for North America, Europe and Asia
* Led the development team new assays and biometrics
* Acted as the Scientific Global Marketing representative for MDS Pharma
Services
* Served as chairman of the product line development and target identification
team
* Supervised of 10 scientific directors in various drug development sectors
* Developed the guiding principles for the growth of pharmacology assay revenue
and profitability
MDS Pharma Services (Drug discovery, Development and Preclinical) 2001-2002
Associate Director of Pharmacology
MAJOR AREAS OF RESPONSIBILITY
* Provided Business Development support for North America, Asia and Europe
* Served as scientific subject manner expert for product catalog and services
* Responsible for the scientific support of all biological assays
* Led the implementation of the Xenogen technology project (oncology and
infectious diseases )
AstraZeneca (merge with Astra in 1999) 1994-2001
AstraZeneca R&D Montreal
Assistant Director Pharmacology
MAJOR AREAS OF RESPONSIBILITY
* Headed in vivo pharmacology and administrator of the animal facility
* Led of general pharmacology (in vitro) and toxicology teams.
* Served as companywide representative of management for individual and team
performance for AZ.
* Nominated CD from R&D libraries and selected follow-ups
* Managed drug development from animal to human (proof of concept)
* Evaluated Toxicology and CROs, recruitment and data analysis
* Authored documentation for pre-CD, CD nomination and IND
Astra Pain Control
Astra Research Centre Montreal (ARCM)
* Assistant Director 1997-2001
* Group Leader (in vivo pharmacology and DM/PK group) 1996-1997
* Section head (in vivo pharmacology and DM/PK group) 1995-1996
* Administrator/ negotiator 1994-1995
PREVIOUS EMPLOYMENT HISTORY
1992-1994 Post-doctoral Fellow
Dr Rémi Quirion's Neuropsychopharmacology Laboratory
Douglas Hospital Research Centre, Verdun
McGill University
1992 Training / Post Doc
Dr Khem Jhamandas's Laboratory
Queen's University, Kingston Ontario
Dept. Pharmacology and Toxicology
1992-96 Ph.D. Program
Supervisor: Dr Francois Jolicoeur
Centre Hospitalier Universitaire, Sherbrooke
Psychiatry, Ophthalmology and Pharmacology Dept.
1988-91 Research Assistant (Senior) and Student
Dr Francois Jolicoeur's Laboratory
Centre Hospitalier Universitaire, Sherbrooke
Psychiatry and Pharmacology Dept.
Dr Bernard Belleau
Biochem Pharma
EDUCATION
Ph.D. Neuropharmacology 1996
Centre Hospitalier Universitaire Sherbrooke
Post-Doctoral Fellow
Neuropharmacology 1994
Douglas Hospital Research Center
McGill University
M.Sc./Ph.D. Pharmacology 1992
Centre Hospitalier Universitaire Sherbrooke
B.Sc. Neuropsychology 1987
Université de Sherbrooke
CONTINUING EDUCATION
MEDICAL
* Pain Education Day (3 MAINPRO-M1) University of Calgary
* Pain 2000 (14 MAINPRO-M1) University of Calgary
* Mechanisms of treatment of neuropathic pain, International meetings and
science inc.
MANAGEMENT
* Management courses (5) at Astra
* Passed MDSPS Corporate Evaluation with mark of excellence 2002
* MDS Inc , Leadership of excellence program 2002
* MDS Inc. Executive Management Team, Leadership Forum 2003/2005
* Balance scorecard implementation 2004
* Lean Sigma process (Green belt training) 2 |
